Antibody Information
General Information of This Antibody
| Antibody ID | ANI0DYEJC |
|||||
|---|---|---|---|---|---|---|
| Antibody Name | Blinatumomab |
|||||
| Brand Name | BLINCYTO |
|||||
| Organization | Amgen, Inc.; BeiGene Ltd.; MedImmune LLC |
|||||
| Indication | B cell acute lymphoblastic leukemia; Burkitt's lymphoma; B-cell acute lymphoblastic leukemia |
|||||
| Approval Date | Dec. 2014 |
|||||
| Synonyms |
MEDI-538; MT-103; AMG103; BITE MT-103; bscCD19xCD3; MEDI-538; MT103
Click to Show/Hide
|
|||||
| Antibody Type | Bispecific antibody (BsAb) |
|||||
| Antibody Subtype | Murine IgG |
|||||
| Antigen Name | B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3;TPBG) |
Antigen Info | ||||
| ChEMBI ID | ||||||
| DrugBank ID | ||||||
| Drug Central ID | ||||||
| Click to Show/Hide the Sequence Information of This Antibody | ||||||
| Heavy Chain Sequence |
DIQLTQSPASLAVSLGQRATISCKASQSVDYDGDSYLNWYQQIPGQPPKLLIYDASNLVS
GIPPRFSGSGSGTDFTLNIHPVEKVDAATYHCQQSTEDPWTFGGGTKLEIKGGGGSGGGG SGGGGSQVQLQQSGAELVRPGSSVKISCKASGYAFSSYWMNWVKQRPGQGLEWIGQIWPG DGDTNYNGKFKGKATLTADESSSTAYMQLSSLASEDSAVYFCARRETTTVGRYYYAMDYW GQGTTVTVSSGGGGSDIKLQQSGAELARPGASVKMSCKTSGYTFTRYTMHWVKQRPGQGL EWIGYINPSRGYTNYNQKFKDKATLTTDKSSSTAYMQLSSLTSEDSAVYYCARYYDDHYC LDYWGQGTTLTVSSVEGGSGGSGGSGGSGGVDDIQLTQSPAIMSASPGEKVTMTCRASSS VSYMNWYQQKSGTSPKRWIYDTSKVASGVPYRFSGSGSGTSYSLTISSMEAEDAATYYCQ QWSSNPLTFGAGTKLELKHHHHHH Click to Show/Hide
|
|||||
Each Antibody-drug Conjugate Related to This Antibody
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.